BepiPred-3.0

BepiPred-3.0 predicts B-cell epitopes by using protein language model embeddings derived from amino acid sequences to identify linear and conformational epitopes for vaccine design and immunological studies.

Key Features:

• Protein language models (LMs): Uses advanced LMs trained on extensive datasets of protein sequences and structures.
• LM embeddings: Employs numeric embeddings from LMs as primary input representations for prediction.
• Sequence-only representations: Derives powerful numeric representations from amino acid sequences alone.
• Epitope types predicted: Predicts both linear (continuous) and conformational (discontinuous) B-cell epitopes.
• Structural feature capture: Embeddings capture local and global structural features relevant to epitope identification.
• Input variable selection: Integrates carefully selected input variables to improve predictive performance.
• Epitope residue annotation: Uses an optimized epitope residue annotation strategy.
• Validation: Demonstrates improved prediction accuracy across multiple independent test sets.
• Scalability: Capable of processing hundreds of sequences within minutes.

Scientific Applications:

• Vaccine development: Identifies B-cell epitopes to prioritize antigenic regions for vaccine antigen design.
• Disease diagnostics: Supports selection of epitope targets for diagnostic reagent and assay development.
• Large-scale immunological studies: Enables high-throughput epitope prediction across many protein sequences.
• Epitope mapping: Facilitates mapping of antigenic regions to analyze immune responses and antigenicity.

Methodology:

Uses protein language models trained on protein sequences and structures to produce embeddings from amino acid sequences, integrates these LM embeddings with selected input variables and an optimized epitope residue annotation strategy, and evaluates predictions on independent test sets to predict linear and conformational B-cell epitopes.